SUNSHINE OIL (02012) reported a second-quarter performance with a net loss attributable to shareholders of 19.74 million Canadian dollars, an increase of 896.47% year-on-year.

17:27 12/08/2026

Sunshine Oilsands (02012) released its second quarter results for the period ending June 30, 2026, reporting a total loss of CAD 4.7 million, turning from profit to loss compared to the same period last year; the net loss attributable to shareholders was CAD 19.74 million, an increase of 896.47% year-on-year; basic loss per share was CAD 0.03.

SUNSHINE OIL (02012) released its second quarter results for the period ending June 30, 2026, showing a total loss of CAD 4.7 million, a shift from profit to loss compared to the same period last year; the net loss attributable to shareholders was CAD 19.74 million, an increase of 896.47% year-on-year; basic loss per share was CAD 0.03.

ORIENTAL EXPL (00430) issues a profit warning, expecting that integrated profit attributable to shareholders for the first half of the year will decrease to approximately HK$3 million to HK$3.2 million.

Jiangsu Hengrui Pharmaceuticals (01276): SHR-7590 injection has obtained the Drug Clinical Trial Approval Notification.

CHINA RES LAND (01109) reported a cumulative contract sales amount of approximately 130.6 billion yuan for the first seven months, an increase of 5.7% year-on-year.

Jiangsu Hengrui Pharmaceuticals (01276): SHR-7590 injection has obtained the Drug Clinical Trial Approval Notification.

CHINA RES LAND (01109) reported a cumulative contract sales amount of approximately 130.6 billion yuan for the first seven months, an increase of 5.7% year-on-year.